Our Company
- Our Company
Products
- Clinical UHS
- Clinical NGS
Our Technology
- Our Technology
Investors & Media
- Press release
- Publication
Careers
- Careers

TEL
02-468-7542

FAX
02-468-7543

ADDRESS
Room 407, Seongsu A-One Center, 48,
Ttukseom-ro 17ga-gil, Seongdong-gu, Seoul

EMAIL
genopeaks@genopeaks.com

Our Company
Products
- Clinical UHS
- Clinical NGS
Our Technology
Investors & Media
- Press release
- Publication
Careers

Investors & Media

Investors & Media

Our Company
Products
Our Technology
Investors & Media
Careers

Publication

Press release
Publication

Next-Generation Sequencing Using S1 Nuclease for Poor-Qualit… Next-Generation Sequencing Using S1 Nuclease for…
18-06-21

Next-generation sequencing (NGS) testing of formalin-fixed, paraffin-embedded (FFPE) …

Next-generation sequencing (NGS) testing …

View More
Feasibility of multiplexed gene mutation detection in plasma… Feasibility of multiplexed gene mutation detecti…
17-05-01

Mutation analysis of circulating tumor DNA (ctDNA) has recently been intro…

Mutation analysis of circulating tumor&n…

View More

게시물 검색

검색대상 검색어 필수

Terms of Service

Privacy Policy

Room 407, Seongsu A-One Center, 48, Ttukseom-ro 17ga-gil, Seongdong-gu, Seoul CEO. Chinkoo Jung

Tel. 02-468-7542 Fax. 02-468-7543E-mail. genopeaks@genopeaks.com

Copyright©2016 ILOGIN. All rights reserved.

제노픽스